The results of network pharmacology suggest that catalpol is involved in the regulation of inflammation, vascular homeostasis, and vascular remodeling after cerebral ischemia, which is closely related to F2, MMP9, VEGF/KDR, and ALB. Here, VEGFA is linked to brain ischemia.